Drugs / GMM-2 NS
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02870205 Comparator | Aug 2016 → Jan 2017 | seasonal allergic rhinitis | Glenmark Specialty S.A. | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GMM-2 NS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02870205 ↗ |